We also invest in for-profit ventures that show potential to improve human well-being at scale.

Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.

  1. OliLux Biosciences

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in OliLux Biosciences to support the development of diagnostic and treatment monitoring tools for the detection and management of tuberculosis.

    Date of Investment:
    01/2021
    Read More:
    Open Philanthropy Page
  2. VasoRX

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VasoRX to support work work testing a new therapy for vascular diseases such as atherosclerosis and pulmonary arterial hypertension.

    Date of Investment:
    11/2020
    Read More:
    Open Philanthropy Page
  3. Binx

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Binx to support work to incorporate Sherlock Biosciences's COVID-19 assay into Binx's point-of-care diagnostic platform.

    Date of Investment:
    11/2020
    Read More:
    Open Philanthropy Page
  4. Riboscience

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Riboscience to support work to test a new drug candidate against COVID-19.

    Date of Investment:
    09/2020
    Read More:
    Open Philanthropy Page
  5. Icosavax

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Icosavax to support the development of a new nanoparticle COVID-19 vaccine.

    Date of Investment:
    08/2020
    Read More:
    Open Philanthropy Page
  6. VST Bio

    Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VST Bio to support the development of a novel treatment for stroke and traumatic brain disease. 

    Date of Investment:
    07/2020
    Read More:
    Open Philanthropy Page